CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells

British Journal of Haematology

Volumn 153, Issue 4, 2011, Pages 486-498

  Porakishvili, Nino ^a   Memon, Azka ^a   Vispute, Ketki ^a   Kulikova, Nina ^a   Clark, Edward A ^b   Rai, Kanti R ^c   Nathwani, Amit ^d   Damle, Rajendra N ^c   Chiorazzi, Nicholas ^c   Lydyard, Peter M ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; CD180 RP105; Chronic lymphocytic leukaemia; Immunohaematology; Signalling

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD180; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL CYCLE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MONOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD40; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DRUG SYNERGISM; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 79955024434     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08605.x     Document Type: Article

References (53)

1. Akashi-Takamura, S. & Miyake, K. (2008) TLR accessory molecules. Current Opinion in Immunology, 20, 420-425.
2. Bernasconi, N.L., Onai, N. & Lanzavecchia, A. (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 101, 4500-4504.
3. Chan, V.W., Mecklenbräuker, I., Su, I., Texido, G., Leitges, M., Carsetti, R., Lowell, C.A., Rajewsky, K., Miyake, K. & Tarakhovsky, A. (1998) The molecular mechanism of B cell activation by toll-like receptor protein RP-105. Journal of Experimental Medicine, 188, 93-101.
4. Chiorazzi, N. & Ferrarini, M. (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annual Review of Immunology, 21, 841-894.
5. Chiorazzi, N., Rai, K.R. & Ferrarini, M. (2005) Chronic lymphocytic leukemia. New England Journal of Medicine, 352, 804-815.
6. Chiron, D., Bekeredjian-Ding, I., Pellat-Deceunynck, C., Bataille, R. & Jego, G. (2008) Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood, 112, 2205-2213.
7. Clark, E.A. & Ledbetter, J.A. (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proceedings of the National Academy of Sciences USA, 83, 4494-4498.
8. Clark, E.A. & Shu, G. (1987) Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors. Journal of Immunology, 138, 720-725.
9. Clark, E.A., Shu, G.L., Luscher, B., Draves, K.E., Banchereau, J., Ledbetter, J.A. & Valentine, M.A. (1989) Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals. Journal of Immunology, 143, 3873-3880.
10. Crespo, M., Bosch, F., Villamor, N., Bellosillo, B., Colomer, D., Rozman, M., Marcé, S., López-Guillermo, A., Campo, E. & Montserrat, E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine, 348, 1764-1775.
11. Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840-1847.
12. Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. & Sarfati, M. (1992) Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. Journal of Experimental Medicine, 176, 1319-1326.
13. Dasari, P., Nicholson, I.C., Hodge, G., Dandie, G.W. & Zola, H. (2005) Expression of Toll-like receptors on B lymphocytes. Cellular Immunology, 236, 140-145.
14. Divanovic, S., Trompette, A., Atabani, S.F., Madan, R., Golenbock, D.T., Visintin, A., Finberg, R.W., Tarakhovsky, A., Vogel, S.N., Belkaid, Y., Kurt-Jones, E.A. & Karp, C.L. (2005) Negative regulation of Toll-like receptor 4 signalling by the Toll-like receptor homolog RP105. Nature Immunology, 6, 571-578.
15. Divanovic, S., Trompette, A., Petiniot, L.K., Allen, J.L., Flick, L.M., Belkaid, Y., Madan, R., Haky, J.J. & Karp, C.L. (2007) Regulation of TLR4 signaling and the host interface with pathogens and danger: the role of RP105. Journal of Leukocyte Biology, 82, 265-271.
16. Elgueta, R., Benson, M.J., de Vries, V.C., Wasiuk, A., Guo, Y. & Noelle, R.J. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews, 229, 152-172.
17. Fluckiger, A.C., Li, Z., Kato, R.M., Wahl, M.I., Ochs, H.D., Longnecker, R., Kinet, J.P., Witte, O.N., Scharenberg, A.M. & Rawlings, D.J. (1998) Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. The EMBO Journal, 17, 1973-1985.
18. Foote, L.C., Howard, R.G., Marshak-Rothstein, A. & Rothstein, T.L. (1996) IL-4 induces Fas resistance in B cells. Journal of Immunology, 157, 2749-2753.
19. Fugier-Vivier, I., de Bouteiller, O., Guret, C., Fossiez, F., Banchereau, J., Mattei, M.G., Aït-Yahia, S., Garcia, E., Lebecque, S. & Liu, Y.J. (1997) Molecular cloning of human RP105. European Journal of Immunology, 27, 1824-1827.
20. Gauld, S.B., Merrell, K.T. & Cambier, J.C. (2006) Silencing of autoreactive B cells by anergy: a fresh perspective. Current Opinion in Immunology, 18, 292-297.
21. Ghia, P., Circosta, P., Scielzo, C., Vallario, A., Camporeale, A., Granziero, L. & Caligaris-Cappio, F. (2005) Differential effects on CLL cell survival exerted by different microenvironmental elements. Current Topics in Microbiology and Immunology, 294, 135-145.
22. Ghia, P., Ferreri, A.M. & Galigaris-Cappio, F. (2007) Chronic lymphocytic leukemia. Critical Reviews in Oncology/Hematology, 64, 234-246.
23. Ghia, P., Chiorazzi, N. & Stamatopoulos, K. (2008) Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. Journal of Internal Medicine, 264, 549-562.
24. Good, K.L., Avery, D.T. & Tangye, S.G. (2009) Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. Journal of Immunology, 182, 890-901.
25. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood, 94, 1848-1854.
26. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S. & Hartmann, G. (2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of Immunology, 168, 4531-4537.
27. Jones, D.T., Ganeshaguru, K., Virchis, A.E., Folarin, N.I., Lowdell, M.W., Mehta, A.B., Prentice, H.G., Hoffbrand, A.V. & Wickremasinghe, R.G. (2001) Caspase 8 activation independent of Fas (CD95/APO-1) signalling may mediate killing of B-chronic lymphocytic leukaemia cells by cytotoxic drugs or γ-radiation. Blood, 98, 2800-2807.
28. Kay, N.E. & Pittner, B.T. (2003) IL-4 biology: impact on normal and leukemic CLL B cells. Leukemia and Lymphoma, 44, 897-903.
29. Liu, Y.J., Joshua, D.E., Williams, G.T., Smith, C.A., Gordon, J. & MacLennan, I.C. (1989) Mechanism of antigen-driven selection in germinal centres. Nature, 342, 929-931.
30. Mainou-Fowler, T., Proctor, S.J., Miller, S. & Dickinson, A.M. (2001) Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia. Leukemia and Lymphoma, 42, 89-698.
31. Mentz, F., Mossalayi, M.D., Ouaaz, F., Baudet, S., Issaly, F., Ktorza, S., Semichon, M. & Binet, J.L. (1996) Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukaemia cells. Blood, 88, 2172-2182.
32. Merrell, K.T., Benschop, R.J., Gauld, S.B., Aviszus, K., Decote-Ricardo, D., Wysocki, L.J. & Cambier, J.C. (2006) Identification of anergic B cells within a wild-type repertoire. Immunity, 25, 953-962.
33. Miura, Y., Miyake, K., Yamashita, Y., Shimazu, R., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Inazawa, J., Abe, T. & Kimoto, M. (1996) Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics, 38, 299-304.
34. Miura, Y., Shimazu, R., Miyake, K., Akashi, S., Ogata, H., Yamashita, Y., Narisawa, Y. & Kimoto, M. (1998) RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood, 92, 2815-2822.
35. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K. & Kimoto, M. (1994) Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. Journal of Experimental Medicine, 180, 1217-1224.
36. Miyake, K., Yamashita, Y., Ogata, M., Sudo, T. & Kimoto, M. (1995) RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. Journal of Immunology, 154, 3333-3340.
37. Muzio, M., Apollonio, B., Scielzo, C., Frenquelli, M., Vandoni, I., Boussiotis, V., Caligaris-Cappio, F. & Ghia, P. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood, 112, 188-195.
38. Nagai, Y., Shimazu, R., Ogata, H., Akashi, S., Sudo, K., Yamasaki, H., Hayashi, S., Iwakura, Y., Kimoto, M. & Miyake, K. (2002) Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood, 99, 1699-1705.
39. Noelle, R.J., Ledbetter, J.A. & Aruffo, A. (1992) CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunology Today, 13, 431-433.
40. Ogata, H., Su, I., Miyake, K., Nagai, Y., Akashi, S., Mecklenbräuker, I., Rajewsky, K., Kimoto, M. & Tarakhovsky, A. (2000) The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. Journal of Experimental Medicine, 192, 23-29.
41. Otipoby, K.L., Nagai, Y., Shu, G.L., Miyake, K. & Clark, E.A. (2002) CD180 (RP105/Bgp95) workshop report. In: Leukocyte Typing VII. White Cell Differentiation Antigens. (eds by D.Y. Mason, A. Besussan, C. Buckley, C. Civin, E. Clark, M. de Haas, S. Govert, D. Hart, Horejsi & Y. Jones ), pp. 120-123. Oxford University Press, BC7, USA.
42. Petroni, K.C., Shen, L. & Guyre, P.M. (1988) Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-γ and glucocorticoids. Journal of Immunology, 140, 3467-3472.
43. Porakishvili, N., Kardava, L., Jewell, A.P., Yong, K., Glennie, M., Akbar, A. & Lydyard, P.M. (2004) Perforin expressing CD4+T cells in patients with B cell chronic lymphocytic leukemia (B-CLL) are cytotoxic. Haematologica, 89, 435-443.
44. Porakishvili, N., Kulikova, N., Jewell, A.P., Youinou, P.Y., Yong, K., Nathwani, A., Heelan, B., Duke, V., Hamblin, T.J., Wallace, P., Ely, P., Clark, E.A. & Lydyard, P.M. (2005) Differentiational expression of CD180 by B chronic lymphocytic leukaemic cells with mutated and unmutated Ig Vh genes. British Journal of Haematology, 131, 313-319.
45. Roshak, A.K., Anderson, K.M., Holmes, S.D., Jonak, Z., Bolognese, B., Terrett, J. & Marshall, L.A. (1999) Anti-human RP105 sera induces lymphocyte proliferation. Journal of Leukocyte Biology, 65, 43-49.
46. Schwering, I., Bräuninger, A., Klein, U., Jungnickel, B., Tinguely, M., Diehl, V., Hansmann, M.L., Dalla-Favera, R., Rajewsky, K. & Küppers, R. (2003) Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood, 101, 1505-1512.
47. Stevenson, F.K. & Caligaris-Cappio, F. (2004) Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood, 103, 4389-4395.
48. Tuscano, J.M., Druey, K.M., Riva, A., Pena, J., Thompson, C.B. & Kehrl, J.H. (1996) Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood, 88, 1359-1364.
49. Valentine, M.A., Clark, E.A., Shu, G.L., Norris, N.A. & Ledbetter, J.A. (1988) Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation. Journal of Immunology, 140, 4071-4078.
50. Van den Eertwegh, A.J., Noelle, R.J., Roy, M., Shepherd, D.M., Aruffo, A., Ledbetter, J.A., Boersma, W.J. & Claassen, E. (1993) In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. Journal of Experimental Medicine, 178, 1555-1565.
51. Yamashita, Y., Miyake, K., Miura, Y., Kaneko, Y., Yagita, H., Suda, T., Nagata, S., Nomura, J., Sakaguchi, N. & Kimoto, M. (1996) Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation. Journal of Experimental Medicine, 184, 113-120.
52. Yazawa, N., Fujimoto, M., Sato, S., Miyake, K., Asano, N., Nagai, Y., Takeuchi, O., Takeda, K., Okochi, H., Akira, S., Tedder, T.F. & Tamaki, K. (2003) CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood, 102, 1374-1380.
53. Zhuang, J., Hawkins, S.F., Glenn, M.A., Lin, K., Johnson, G.G., Carter, A., Cawley, J.C. & Pettitt, A.R. (2010) Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition. Haematologica, 95, 110-118.